| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |